Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS".

Loading news article.

Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS". | WAPE

Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS".

Article summary

Related companies

Comments —